LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $6,142,134

Key CONT_AWD_75N91022F00017_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 354 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91022F00017_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91022F00017_7529_75N91019D00024_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:55:19Z

Content hash f8d7bc0122d2bed2c048e8cfd423d087017f3e992d458e1662b3e9d2bec8af0f

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$6,142,134	first version	September 16, 2022	September 16, 2025	2026-09-05T00:55:19Z	historical sweep	`f8d7bc0122d2`

Archived copy

https://web.archive.org/web/20261014051714/https://www.usaspending.gov/award/CONT_AWD_75N91022F00017_7529_75N91019D00024_7529 captured by this system, October 14, 2026

What the amount is made of

5 recorded actions, so the amount is the award's current total across all of them. 1 of them obligated money. Measured 2026-10-11, when USAspending reported a total obligation of $6,142,134.

Action date	Modification	Type	Obligated	Description as recorded
September 16, 2025	P00004	TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL)	no money	EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL MODIFICATION TO CANCEL UNEXERCISED OPTIONS
December 19, 2024	P00003	OTHER ADMINISTRATIVE ACTION	no money	NIAID-DMID-ANTIVIRAL PROGRAM FOR PANDEMICS EARLY PHASE CLINICAL TRIAL(S)
February 13, 2024	P00002	OTHER ADMINISTRATIVE ACTION	no money	NIAID-DMID-ANTIVIRAL PROGRAM FOR PANDEMICS EARLY PHASE CLINICAL TRIAL(S)
January 31, 2023	P00001	OTHER ADMINISTRATIVE ACTION	no money	NIAID-DMID-ANTIVIRAL PROGRAM FOR PANDEMICS EARLY PHASE CLINICAL TRIAL(S)
September 16, 2022	base	not on file	+$6,142,134	NIAID-DMID-ANTIVIRAL PROGRAM FOR PANDEMICS EARLY PHASE CLINICAL TRIAL(S)

Last refreshed November 4, 2026 at 2:31 PM UTC.